Venetoclax for the Treatment of Chronic Lymphocytic Leukemia

Purpose of this Review This review summarizes the role of BCL-2 in the pathogenesis of CLL, and the clinical data evaluating safety and efficacy of venetoclax, in treatment of patients with CLL, in the context of other available targeted agents.